For R&D use only.

Darapladib

  • Catalog NO.:A822896
  • CAS No. : 356057-34-6
  • Molecular Formula:C36H38F4N4O2S
  • Molecular Weight: 666.77
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
SDS COA NMR

Product Details

CAS Number 356057-34-6 Appearance White powder
Catalog Number A822896 MDL Number MFCD18251452
Molecular Formula C36H38F4N4O2S Molecular Weight 666.77
Boiling Point 741.002°C at 760 mmHg Melting Point
Flash Point Density
Synonyms SB 480848;N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-Cyclopentapyrimidine-1-acetamide
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Darapladib, also known as SB-480848, is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM, which is in Phase 3 trials. Recent studies showed that risk of major coronary events not reduced by darapladib therapy. In patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke.

Related Products

My Tracks: Darapladib
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Darapladib
SB 480848;N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-Cyclopentapyrimidine-1-acetamide